Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J. Aguirre, William C. Hahn, Robin M. Meyers et al.|Cancer Discovery|2016Cited by 632
Cas9 activates the p53 pathway and selects for p53-inactivating mutationsOana M. Enache, Uri Ben‐David, Verónica Rendo et al.|Nature Genetics|2020Cited by 285
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data setsJoshua M. Dempster, Francesco Iorio, Victor Zhivich et al.|Nature Communications|2019Cited by 281
High-throughput Phenotyping of Lung Cancer Somatic MutationsAlice H. Berger, Jesse S. Boehm, Angela N. Brooks et al.|Cancer Cell|2016Cited by 224